These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25458914)

  • 1. Meeting report VLPNPV: Session 10: Virus-like particle and nano-particle vaccines.
    Effio CL; Hubbuch J
    Hum Vaccin Immunother; 2014; 10(10):3080-2. PubMed ID: 25458914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting report VLPNPV: Session 8: Vaccines I.
    Thiriot DS
    Hum Vaccin Immunother; 2014; 10(10):3078-9. PubMed ID: 25483643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting report VLPNPV: Session 7: Respiratory.
    Skibinski D
    Hum Vaccin Immunother; 2014; 10(10):3077. PubMed ID: 25459227
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress in the development of virus-like particle vaccines against respiratory viruses.
    Quan FS; Basak S; Chu KB; Kim SS; Kang SM
    Expert Rev Vaccines; 2020 Jan; 19(1):11-24. PubMed ID: 31903811
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
    Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
    Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting report VLPNPV: Session 6: Development and characterization.
    Rutkowska D
    Hum Vaccin Immunother; 2014; 10(10):3074-6. PubMed ID: 25458600
    [No Abstract]   [Full Text] [Related]  

  • 7. Meeting report VLPNPV: Sessions 1 and 2: Plenary.
    Sainsbury F
    Hum Vaccin Immunother; 2014; 10(10):3060-3. PubMed ID: 25485812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
    Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
    Hwang HS; Lee YT; Kim KH; Ko EJ; Lee Y; Kwon YM; Kang SM
    Virology; 2017 Nov; 511():142-151. PubMed ID: 28846899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
    Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
    Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
    Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus.
    Urakami A; Sakurai A; Ishikawa M; Yap ML; Flores-Garcia Y; Haseda Y; Aoshi T; Zavala FP; Rossmann MG; Kuno S; Ueno R; Akahata W
    Clin Vaccine Immunol; 2017 Jul; 24(7):. PubMed ID: 28515133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting report VLPNPV: Session 10: Rapid total particle quantification.
    Artinger M
    Hum Vaccin Immunother; 2014; 10(10):3083-6. PubMed ID: 25511481
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
    Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meeting report VLPNPV: Session 3: Immune responses.
    Morrison TG
    Hum Vaccin Immunother; 2014; 10(10):3064-7. PubMed ID: 25529229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference.
    Engeroff P; Bachmann MF
    Expert Rev Vaccines; 2019 Jan; 18(1):1-3. PubMed ID: 30526126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meeting report VLPNPV: Session 5: Plant based technology.
    Meador LR; Mor TS
    Hum Vaccin Immunother; 2014; 10(10):3068-73. PubMed ID: 25581535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants.
    Le Mauff F; Mercier G; Chan P; Burel C; Vaudry D; Bardor M; Vézina LP; Couture M; Lerouge P; Landry N
    Plant Biotechnol J; 2015 Jun; 13(5):717-25. PubMed ID: 25523794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in developing virus-like particle influenza vaccines.
    Quan FS; Lee YT; Kim KH; Kim MC; Kang SM
    Expert Rev Vaccines; 2016 Oct; 15(10):1281-93. PubMed ID: 27058302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.